Narcolepsy Market 2019 Revenue and Forecast to 2027

1
Narcolepsy Market
Publication Month Feb 2019 Report Code
TIPRE00003326 No. of Pages 156 Category
Pharmaceuticals Status Published
Narcolepsy Market to 2027 - Global Analysis and
Forecasts by Type (Narcolepsy with Cataplexy,
Narcolepsy without Cataplexy, and Secondary
Narcolepsy) Product (Central Nervous System
(CNS) Stimulants, Sodium Oxybate, and
Antidepressants) Distribution Channel (Hospital
Pharmacies and Retail Pharmacies) and Geography
E-Mail  sales_at_theinsightpartners.com
2
Narcolepsy Market
Publication Month Feb 2019 Report Code
TIPRE00003326 No. of Pages 156 Category
Pharmaceuticals Status Published
Introduction According to a new market
research study titled 'Narcolepsy Market - Global
Analysis and Forecasts by Type, Product and
Distribution Channel, the global narcolepsy
market is expected to reach US 4,537.9 Mn in
2027 from US 2,026.8 Mn in 2018. The market is
estimated to grow with a CAGR of 9.5 from
2019-2027. The report highlights the trends
prevalent in the global narcolepsy market and the
factors driving the market along with those that
act as deterrents to its growth. The narcolepsy
market by type is segmented into narcolepsy with
cataplexy, narcolepsy without cataplexy, and
secondary cataplexy. In 2018, the narcolepsy with
cataplexy segment held a largest market share of
65.1 of the narcolepsy market, by type. This
segment is also expected to dominate the market
in 2027 owing to its significant prevalence among
patients suffering with narcolepsy. Episodes of
cataplexy are reported to be encountered among
55-60 of patients suffering with narcolepsy.
Moreover, the similar segment is anticipated to
also witness the fastest growth rate of 9.7
during the forecast period, 2019 to 2027 owing to
the increasing demand for drugs to treat the
disease.
E-Mail  sales_at_theinsightpartners.com
3
Narcolepsy Market
Publication Month Feb 2019 Report Code
TIPRE00003326 No. of Pages 156 Category
Pharmaceuticals Status Published
Rising prevalence of sleep related neurological
disorders is expected to boost the market growth
over the years The range of sleep disorders that
are treated by neurologists is wide and includes
conditions such as insomnia, sleep apnea,
restless legs syndrome, and narcolepsy. These
disorders cause disruptions in the normal
sleep-wake mechanisms causing endogenous
abnormalities. Neurological sleep related
disorders is an emerging problem as the
population is ageing at a rapid rate. According
to the National Institute of Health (NIH),
approximately 40 million Americans suffer from
neurological diseases in the US, whereas
additional 20 million people experience
occasional sleeping problems. Over the last
decades, much has been learnt about the
pathophysiology of narcolepsy. According to the
National Center for Biotechnology Information,
the prevalence of narcolepsy with cataplexy has
been examined in many studies and falls between
25 and 50 per 100,000 people. Moreover, according
to the Narcolepsy Network 2017, the condition
affects 1 in every 2,000 people in the United
States. Thats 200,000 Americans and
approximately 3 million worldwide. Moreover, the
American Sleep Apnea Association reports that
sleep-related problems affect 50 to 70 million
Americans of all ages and socioeconomic classes.
Sleep disorders are common in both men and women
however, important disparities in prevalence and
severity of certain sleep disorders have been
identified in minorities and underserved
populations. More than 50 million Americans
already suffer from over 80 different sleep
disorders and another 20 to 30 million suffer
intermittent sleep problems each year. The
increasing prevalence of neurological sleep
disorders and narcolepsy is likely to foster the
growth of market in the coming years.
E-Mail  sales_at_theinsightpartners.com
4
Narcolepsy Market
Publication Month Feb 2019 Report Code
TIPRE00003326 No. of Pages 156 Category
Pharmaceuticals Status Published
Increasing Awareness Regarding Neurological
Disorders The relationship between public health
and neurology was not been adequately explored
until recent years. The burden of neurological
disorders have increased significantly across the
world. These disorders are estimated to affect
over a billion population worldwide, according to
the World Health Organization by 2016.
Neurological disorders are commonly found among
all the age groups, in all geographic
populations.  Similarly, sleep related
neurological disorders that comprise a large
group of diseases also affect a substantial
population worldwide. These diseases majorly
includes insomnia, sleep apnea, narcolepsy and
others. However, in the recent years, several
measures have been undertaken so as to generate
awareness and educate the population regarding
these diseases, which is likely to propagate
patients from accessing the available medications
and treatments for these conditions. According to
National Center for Biotechnology Information
2017, clinician and public awareness of various
sleep disorders with the intent of increasing
rates of recognition and treatment. The
increasing awareness in patients and initiatives
undertaken by non-profit parties is expected to
outreach a large patient population regarding the
medications available for the disease, thereby
favoring the market growth.
E-Mail  sales_at_theinsightpartners.com
5
Narcolepsy Market
Publication Month Feb 2019 Report Code
TIPRE00003326 No. of Pages 156 Category
Pharmaceuticals Status Published

• The List of Companies
• Bioprojet
• Teva Pharmaceutical Industries Ltd.
• Jazz Pharmaceuticals, Inc.
• Graymark Healthcare, Inc.
• Arena Pharmaceuticals, Inc.
• Shire (Acquired by Takeda)
• Ligand Pharmaceuticals, Inc.
• Novartis AG, Mylan N.V.
• Shionogi Inc.

Get Sample PDF Brochure
E-Mail  sales_at_theinsightpartners.com